Icon

SOFDRA - (12.45% ; Gel)

SOFPIRONIUM BOTANIX SB INC.
12.45% ; Gel
Less Than $1000 mn
None None
Less Than 5
None
None None
SOFDRA is an anticholinergic indicated for the treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older.
Yes
SOFDRA Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12 Patent 13 Patent 14 Patent 15 Patent 16 Patent 17 Patent 18 Patent 19 Patent 20
*** *********
**** *************** ****** **** *************** ****** ****** ** ****** *** *** ** **** *************** ****** ****** ** ****** *** *** ** **** *************** ****** ****** ** ****** *** *** ** **** *************** ****** ****** ** ****** *** *** ** **** *************** ****** *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** *** **** *************** ******* *********** **** ** *********** ******* *** *********** ****** ******* *********** **** ** *********** ******* *** *********** ****** *******
  1. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **. ** ***,***(*** **, ****). **** **** ********* ** *** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ******* *, ****
  2. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.**,***,*** (*** **, ****). **** **** ********* ** *** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ******* *, ****
  3. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.*,***,***(***** **, ****). **** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** **** **, ****.
  4. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.*,***,*** (******** **, ****). **** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ******** **, ****.
  5. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.*,***,*** (***** **, ****). **** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** ***** **, ****..
  6. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **.*,***,***(***** **, ****). **** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** **** **, ****

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.